Statement - Major International Vaccine Centre to Open in Saskatchewan

OTTAWA, Sept. 16, 2011 /CNW/ - The following is a statement by Russell Williams, President of Canada's Research-Based Pharmaceutical Companies (Rx&D), to celebrate today's grand opening of the International Vaccine Centre (InterVac) by the Vaccine and Infectious Disease Organization and the University of Saskatchewan.

"Rx&D congratulates the Vaccine and Infectious Disease Organization (VIDO) and the University of Saskatchewan on the opening of the world's most advanced containment facility. InterVac's state of-the-art vaccine development will help to address global health issues by contributing to the next generation of innovative vaccines. It will also keep Canada at the forefront of innovative science by training scientists and students from around the world and build upon our national legacy in vaccine development that stretches over a century.

"The Government of Canada's investment demonstrates their commitment to innovation and the development of important new vaccines. It will support research to improve the health of Canadians, strengthen Canada's technology and knowledge infrastructure and generate high-skilled research jobs.

"Each year vaccines save an estimated three million lives world-wide. Rx&D believes we have only begun to harness their full potential and through the efforts of VIDO and Intervac they hold the promise for a healthier and more prosperous future."

About Rx&D

Rx&D is the association of leading research-based pharmaceutical companies dedicated to improving the health of Canadians through the discovery and development of new medicines and vaccines. Our community represents 15,000 men and women working for 50 member companies and invests more than $1 billion in research and development each year to fuel Canada's knowledge-based economy. Guided by our Code of Ethical Practices, our membership is committed to working in partnership with governments, healthcare professionals and stakeholders in a highly ethical manner.

SOURCE CANADA'S RESEARCH-BASED PHARMACEUTICAL COMPANIES (RX

For further information:

Christine Choury
Media Relations
Telephone: 613.236.0455
Email: cchoury@canadapharma.org

Profil de l'entreprise

CANADA'S RESEARCH-BASED PHARMACEUTICAL COMPANIES (RX&D)

Renseignements sur cet organisme


FORFAITS PERSONNALISÉS

Jetez un coup d’œil sur nos forfaits personnalisés ou créez le vôtre selon vos besoins de communication particuliers.

Commencez dès aujourd'hui .

ADHÉSION À CNW

Remplissez un formulaire d'adhésion à CNW ou communiquez avec nous au 1-877-269-7890.

RENSEIGNEZ-VOUS SUR LES SERVICES DE CNW

Demandez plus d'informations sur les produits et services de CNW ou communiquez avec nous au 1‑877-269-7890.